NASDAQ · MBOT
Microbot Medical Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for MBOT: Nov 11, 2026
Microbot Medical Inc. Common Stock is estimated to report earnings on 11/11/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 2 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.08. The reported EPS for the same quarter last year was $-0.07.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.08 | $-0.08 | $-0.08 | 2 |
| Dec 2026 | $-0.08 | $-0.08 | $-0.08 | 2 |
| Mar 2027 | $-0.08 | $-0.08 | $-0.08 | 1 |
| Jun 2027 | $-0.07 | $-0.07 | $-0.07 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Fintel · RTTNews · Zacks- Fintel · Oct 27, 11:58 AM EDTMicrobot Medical Inc. Secures First Office-Based Lab Customer for LIBERTY Endovascular Robotic SystemMicrobot Medical Inc. announced that ELMNT IR, a multisite outpatient interventional radiology practice in California, has signed an order to purchase up to a 12-month supply of the company's LIBERTY Endovascular Robotic System devices. ELMNT IR became the first Office-Based Labo
- RTTNews · Oct 6, 9:10 AM EDTMicrobot Medical Signs Three-Year Distribution Deal For LIBERTY In Israel(RTTNews) – Microbot Medical Inc. (MBOT) said it has entered into a three-year exclusive distribution agreement with Medtechnica Ltd. to market and sell its LIBERTY Endovascular Robotic System in Israel.
- Zacks · Aug 11, 10:25 AM EDTMicrobot Medical Inc. (MBOT) Reports Q2 Loss, Lags Revenue EstimatesMicrobot Medical (MBOT) delivered earnings and revenue surprises of 0.00% and -22.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Jul 23, 6:59 AM EDTNew Strong Buy Stocks for July 23rdPLGO, BLPD, INN, RFIL and MBOT have been added to the Zacks Rank #1 (Strong Buy) List on July 23, 2026.
- Zacks · May 19, 9:35 AM EDTAfter Plunging 22.6% in 4 Weeks, Here's Why the Trend Might Reverse for Microbot Medical (MBOT)Microbot Medical (MBOT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
- Zacks · May 13, 6:40 PM EDTMicrobot Medical Inc. (MBOT) Reports Q1 Loss, Misses Revenue EstimatesMicrobot Medical (MBOT) delivered earnings and revenue surprises of +37.50% and -76.67%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · May 5, 10:32 AM EDTCencora to Report Q2 Earnings: What's in Store for the Stock?COR heads into Q2 earnings with expected steady specialty-driven growth, but customer losses and pricing pressures could temper results.
- Zacks · May 4, 1:41 PM EDTSolventum to Post Q1 Earnings: Is a Beat Likely for the Stock?SOLV gears up for Q1 earnings with modest growth expected, margin pressure looming and cost initiatives plus MedSurg momentum shaping results outlook.
- Zacks · May 4, 1:39 PM EDTDENTSPLY SIRONA to Post Q1 Earnings: What's in Store for the Stock?XRAY heads into Q1 earnings with U.S. softness, tariff pressure and transformation costs weighing on margins as investors watch for signs of stabilization.
- Zacks · May 4, 8:54 AM EDTCan Strong Growth Aid INNV's Q3 Earnings Amid Margin Seasonality?InnovAge heads into fiscal Q3 earnings with strong growth momentum and margin gains, but seasonal cost pressures and fading Medicaid tailwinds may temper near-term upside.
- Zacks · May 4, 8:48 AM EDTRevvity to Report Q1 Earnings: What's in Store for the Stock?RVTY heads into Q1 earnings with Diagnostics strength and Life Sciences stabilization, but China pressures and weak academic demand may temper near-term growth.
- Zacks · Apr 28, 8:50 AM EDTStryker to Report Q1 Earnings: What's in Store for the Stock?SYK heads into Q1 earnings with strong procedure demand and robotic surgery growth, but tariff and cost pressures may test margins.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Microbot Medical Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.